Prurigo Nodularis Analysis, Market Size, Epidemiology, Leading Companies and Competitive Analysis By DelveInsight

March 31 22:26 2020
Prurigo Nodularis Analysis, Market Size, Epidemiology, Leading Companies and Competitive Analysis By DelveInsight

(Albany, US) DelveInsight has launched a new report on Prurigo Nodularis Market Insights, Epidemiology and Market Forecast-2030

DelveInsight’s “Prurigo Nodularis – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Prurigo Nodularis, historical and forecasted epidemiology as well as the Prurigo Nodularis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Prurigo Nodularis market report provides current treatment practices, emerging drugs, Prurigo Nodularis market share of the individual therapies, current and forecasted Prurigo Nodularis market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Prurigo Nodularis treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.

Prurigo Nodularis (PN), one of the various subtypes of prurigo, is a chronic, bothersome-to-debilitating disease of the skin, usually seen as multiple, intensely pruritic, and excoriated nodules erupting on the surfaces of the extremities with intense itching or rubbing. PNs are cutaneous lesions often produced by repetitive scratching; hence the nickname “picker’s nodules”, which may occur as a sequel to chronic pruritus or neurotic excoriations. After establishing a perpetual itch-scratch cycle, lichenification of the skin may ensue, resulting in chronic dermatitis termed lichen simplex chronicus. Several lesions in different stages and sizes, may co-exist in patients with chronic pruritus, which were induced by chronic scratching.

 

Request for :- Prurigo Nodularis free sample page

Epidemiology

The Prurigo Nodularis epidemiology division provide insights about historical and current Prurigo Nodularis patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Report Key facts:- 

1. As per the study conducted by Mullins et al. (2019), a majority of patients with prurigo nodularis were present between ages 51 and 65, though several cases in other age groups have also been described. It seems to be more frequent and more intense in females than in males. It is seen as one of the clinical presentations of adult-onset atopic dermatitis. In HIV positive patients, prurigo nodularis is predictive of advanced immunosuppression.

2. As per DelveInsight’s analysis, it has been observed that most of the patients with Atopic PN account for ~75% of the total diagnosed PN cases, followed by Nonatopic PN (~25%) in the United States. In 2017, there were 116,653 Atopic PN and 38,884 Nonatopic PN patients

Major key companies working on Prurigo Nodularis that are given below:- 

1. Sanofi Pharma Co. 

2. Trevi Therapeutics 

Name of drugs covered are given below:- 

1. Dupilumab

2. Nalbuphine ER 

Table of content

1. Key Insights

2. Executive Summary of Prurigo Nodularis

3. Competitive Intelligence Analysis for Prurigo Nodularis

4. Prurigo Nodularis: Market Overview at a Glance

4.1. Prurigo Nodularis Total Market Share (%) Distribution in 2017

4.2. Prurigo Nodularis Total Market Share (%) Distribution in 2030

5. Prurigo Nodularis: Disease Background and Overview

6. Patient Journey

7. Prurigo Nodularis Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

8.1. Prurigo Nodularis Treatment and Management

8.2. Prurigo Nodularis Treatment Algorithm 

9. Unmet Needs

10. Key Endpoints of Prurigo Nodularis Treatment

11. Marketed Products

12. Emerging Therapies

13. Prurigo Nodularis: Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Prurigo Nodularis

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

20.1. Bibliography

20.2. Report Methodology

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

Why should you buy this report?

  • The report will help in developing business strategies by understanding trends shaping and driving the Prurigo Nodularis market
  • To understand the future market competition in the Prurigo Nodularis market and Insightful review of the key market drivers and barriers
  • Organize sales and marketing efforts by identifying the best opportunities for Prurigo Nodularis in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
  • Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
  • Organize sales and marketing efforts by identifying the best opportunities for Prurigo Nodularis market
  • To understand the future market competition in the Prurigo Nodularis market

Related Reports:-

1. Prurigo Nodularis – Epidemiology Forecast to 2030

2. Prurigo Nodularis – Pipeline Insights, 2020

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/